Europe Electrophysiology Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Indication Type (Atrial Fibrillation, Atrial Flutter, AVNRT & WPW), By Country and Growth Forecast, 2022-2028

The Europe Electrophysiology Market is expected to witness market growth of 8.4% CAGR during the forecast period (2022-2028).

Rising cases of arrhythmia is causing the increase in the demand for electrophysiology devices. In addition, the growing senior population, which is more sensitive to such medical conditions, is boosting the market growth. The growing knowledge of the advantages of EP devices, which have lower dangers & higher success rates than previously utilized devices, has given the market a good outlook. In addition, breakthrough technologies like cryo, laser, & ultrasound ablation, as well as sophisticated mapping systems, are fueling market expansion. Compact and portable varieties are being developed by product makers for patients suffering from hypertension, diabetes, and other medical conditions. Other reasons, such as the growing need for EP devices for continuous monitoring, diagnosis, and treatment of CVDs in both home and hospital settings, as well as considerable advancements in healthcare infrastructure, are likely to fuel the market even more.

As per 2019 figures from the European Society of Cardiology, over 6 million instances of cardiovascular diseases (CVDs) were diagnosed in the European Union, with approximately 11 million CVD cases reported in entire Europe. CVDs are also responsible for roughly 3.9 million deaths in Europe each year. The increasing incidence of cardiovascular disorders is likely to boost the market throughout the forecast period since electrophysiological devices have substantial applications in identifying heart failure rates.

Cryoablation for persistent Atrial Fibrillation was found to be secure, effective, & time-saving, with improved health outcomes in long-term follow-up, according to a study published in Europace in 2020. Additionally, the presence of key players in European countries, as well as the rising trend of product approvals, are projected to propel the studied segment's expansion in the region. For example, Adagio Medical's intelligent Continuous Lesion Ablation System (iCLAS) got a CE mark in June 2020 for use in the endocardial treatment of paroxysmal and chronic atrial fibrillation and atrial flutter. Likewise, CardioFocus Inc., or evaluated the CE mark for its HeartLight X3 Endoscopic Ablation System in April 2019, which employs laser energy in a pulmonary vein isolation operation to produce lines of scar tissue to block the faulty electrical pathways that cause atrial fibrillation.

The Germany market dominated the Europe Electrophysiology Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $773.2 million by 2028. The UK market is anticipated to grow at a CAGR of 7.5% during (2022-2028). Additionally, The France market is expected to showcase a CAGR of 9.2% during (2022-2028).

Based on Type, the market is segmented into Electrophysiology Laboratory Devices, Electrophysiology Diagnostic Catheters, Electrophysiology Ablation Catheters, Electrophysiology Access Devices, and Others. Based on Electrophysiology Laboratory Devices Type, the market is segmented into ICE Ultrasound Imaging Systems, Electrophysiology X-Ray Systems, Radiofrequency (RF) Ablation Systems, 3D Mapping Systems & Electrophysiology Recording Systems, and Electrophysiology Remote Magnetic & Robotic Navigation Systems. Based on Electrophysiology Diagnostic Catheters Type, the market is segmented into Conventional, Ultrasound, and Advanced. Based on Electrophysiology Ablation Catheters Type, the market is segmented into Laser, Cryoablation, and Radiofrequency (RF) & Microwave. Based on End User, the market is segmented into Hospitals & Cardiac centres, and Ambulatory Surgery Centers. Based on Indication type, the market is segmented into Atrial Fibrillation, Atrial Flutter, AVNRT & WPW, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, General Electric (GE) Co. (GE Healthcare), Medtronic PLC, Koninklijke Philips N.V., Siemens Healthineers AG, Johnson & Johnson, MicroPort Scientific Corporation, Stereotaxis Inc., and Acutus Medical, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Electrophysiology Laboratory Devices
  • ICE Ultrasound Imaging Systems
  • Electrophysiology X-Ray Systems
  • Radiofrequency (RF) Ablation Systems
  • 3D Mapping Systems & Electrophysiology Recording Systems
  • Electrophysiology Remote Magnetic & Robotic Navigation Systems
• Electrophysiology Diagnostic Catheters
  • Conventional
  • Ultrasound
  • Advanced
• Electrophysiology Ablation Catheters
  • Laser
  • Cryoablation
  • Radiofrequency (RF) & Microwave
• Electrophysiology Access Devices
• Others

By End User

• Hospitals & Cardiac centres
• Ambulatory Surgery Centers

By Indication type

• Atrial Fibrillation
• Atrial Flutter
• AVNRT & WPW
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Boston Scientific Corporation
• General Electric (GE) Co. (GE Healthcare)
• Medtronic PLC
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Johnson & Johnson
• MicroPort Scientific Corporation
• Stereotaxis Inc.
• Acutus Medical, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free